VSCI: Summary for Vision-Sciences, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 4:52am EST - Canadian Markets open in 4 hours and 38 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Vision-Sciences Inc. (VSCI)

On Nov 23: 1.27 USD 0.00 (0.00%)

MORE ON VSCI

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Vision-Sciences, Inc. (NCM:VSCI) Delayed quote data

Last Trade:	1.27 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	1.27
Open:	N/A
Bid:	1.09 x 400
Ask:	1.61 x 400
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.75 - 2.74
Volume:	0
Avg Vol (3m):	56,812.3
Market Cap:	46.81M
P/E (ttm):	2.29
EPS (ttm):	0.55
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add VSCI to Portfolio

Download Data

HEADLINES

•	VISION SCIENCES INC /DE/ Financials
	EDGAR Online Financials (Wed, Nov 18)

•	VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
	EDGAR Online (Fri, Nov 13)

•	Vision-Sciences, Inc. Announces $6.2 Million in Revenue for the First Half of Fiscal 2010
	GlobeNewswire (Thu, Nov 12)

•	VISION SCIENCES INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
	EDGAR Online (Thu, Nov 12)

•	Vision-Sciences, Inc. Does Not Satisfy Nasdaq's Requirement to Maintain a Majority of Independent Directors
	GlobeNewswire (Thu, Nov 12)

•	Q2 2010 Vision-Sciences, Inc. Earnings Release - After Market Close
	CCBN (Thu, Nov 12)

•	Vision-Sciences, Inc. Appoints Warren Bielke Interim Chief Executive Officer
	GlobeNewswire (Mon, Nov 9)

•	VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Wed, Oct 21)

•	VISION SCIENCES INC /DE/ Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements an
	EDGAR Online (Thu, Aug 20)

•	VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
	EDGAR Online (Fri, Aug 14)

More Headlines for VSCI...

ANALYST

EPS Est (next year) (Dec-69) :	N/A
EPS Est (in 2 years) (Dec-69) :	N/A
Avg Rec (current)*:	N/A
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Vision-Sciences, Inc. engages in the design, development, manufacture, and marketing of endoscopes and disposable endosheaths for the medical device market, and flexible borescopes for the industrial device markets primarily in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•